JP2000309505A - Powder cosmetic - Google Patents
Powder cosmeticInfo
- Publication number
- JP2000309505A JP2000309505A JP2000044146A JP2000044146A JP2000309505A JP 2000309505 A JP2000309505 A JP 2000309505A JP 2000044146 A JP2000044146 A JP 2000044146A JP 2000044146 A JP2000044146 A JP 2000044146A JP 2000309505 A JP2000309505 A JP 2000309505A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- component
- water
- powder
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 80
- 239000002537 cosmetic Substances 0.000 title claims abstract description 66
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- -1 gum arabic Chemical compound 0.000 claims abstract description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 23
- 239000007844 bleaching agent Substances 0.000 claims abstract description 3
- 239000000284 extract Substances 0.000 claims description 37
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 7
- 239000002211 L-ascorbic acid Substances 0.000 claims description 5
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 239000007764 o/w emulsion Substances 0.000 claims description 5
- 239000000419 plant extract Substances 0.000 claims description 5
- 229960000401 tranexamic acid Drugs 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 229940088598 enzyme Drugs 0.000 claims description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 229940125697 hormonal agent Drugs 0.000 claims description 3
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 3
- 108010024636 Glutathione Proteins 0.000 claims description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 claims description 2
- 102000001974 Hyaluronidases Human genes 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 241001122767 Theaceae Species 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- 229960002773 hyaluronidase Drugs 0.000 claims description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 2
- 229960004705 kojic acid Drugs 0.000 claims description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 2
- 229960001755 resorcinol Drugs 0.000 claims description 2
- 229960004889 salicylic acid Drugs 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 229960005349 sulfur Drugs 0.000 claims description 2
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 125000000687 hydroquinonyl group Chemical class C1(O)=C(C=C(O)C=C1)* 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000003921 oil Substances 0.000 abstract description 30
- 235000019198 oils Nutrition 0.000 abstract description 29
- 229920003169 water-soluble polymer Polymers 0.000 abstract description 21
- 239000000839 emulsion Substances 0.000 abstract description 16
- 238000003860 storage Methods 0.000 abstract description 14
- 239000003795 chemical substances by application Substances 0.000 abstract description 8
- 239000008213 purified water Substances 0.000 abstract description 4
- 229920000084 Gum arabic Polymers 0.000 abstract description 3
- 235000010489 acacia gum Nutrition 0.000 abstract description 3
- 239000000205 acacia gum Substances 0.000 abstract description 3
- 239000010495 camellia oil Substances 0.000 abstract description 3
- 235000021302 avocado oil Nutrition 0.000 abstract description 2
- 239000008163 avocado oil Substances 0.000 abstract description 2
- 244000165918 Eucalyptus papuana Species 0.000 abstract 1
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 36
- 238000000034 method Methods 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 17
- 239000003814 drug Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 239000004166 Lanolin Substances 0.000 description 11
- 235000019388 lanolin Nutrition 0.000 description 11
- 229940039717 lanolin Drugs 0.000 description 11
- 229910002012 Aerosil® Inorganic materials 0.000 description 10
- 230000007774 longterm Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 9
- 238000002156 mixing Methods 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- 239000001993 wax Substances 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 229920002545 silicone oil Polymers 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000002222 fluorine compounds Chemical class 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- 241000208690 Hamamelis Species 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 238000005354 coacervation Methods 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000008384 inner phase Substances 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 229940114937 microcrystalline wax Drugs 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000008385 outer phase Substances 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- OQUFOZNPBIIJTN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;sodium Chemical compound [Na].OC(=O)CC(O)(C(O)=O)CC(O)=O OQUFOZNPBIIJTN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- IGDCJKDZZUALAO-UHFFFAOYSA-N 2-prop-2-enoxypropane-1,3-diol Chemical compound OCC(CO)OCC=C IGDCJKDZZUALAO-UHFFFAOYSA-N 0.000 description 1
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- JBRMEFWJFBHUKG-UHFFFAOYSA-N 4-[(diaminomethylideneamino)methyl]cyclohexane-1-carboxylic acid Chemical compound NC(N)=NCC1CCC(C(O)=O)CC1 JBRMEFWJFBHUKG-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- UEQVLKWMHAYVLO-MGCOHNPYSA-N C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O Chemical compound C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O UEQVLKWMHAYVLO-MGCOHNPYSA-N 0.000 description 1
- AVWTXYWHGFHGQD-ZKCHVHJHSA-N CNC(=O)[C@H]1CC[C@H](CN)CC1 Chemical compound CNC(=O)[C@H]1CC[C@H](CN)CC1 AVWTXYWHGFHGQD-ZKCHVHJHSA-N 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- XDBMXUKHMOFBPJ-ZAFYKAAXSA-N L-ascorbic acid 2-sulfate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OS(O)(=O)=O)=C1O XDBMXUKHMOFBPJ-ZAFYKAAXSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 235000017822 Melilotus officinalis Nutrition 0.000 description 1
- 240000000366 Melilotus officinalis Species 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- CFRNDJFRRKMHTL-UHFFFAOYSA-N [3-octanoyloxy-2,2-bis(octanoyloxymethyl)propyl] octanoate Chemical compound CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC CFRNDJFRRKMHTL-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 238000011074 autoclave method Methods 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000010574 gas phase reaction Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- POOYFSLWYLDQMD-UHFFFAOYSA-N heptacalcium;zinc Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Zn+2] POOYFSLWYLDQMD-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- NEXSMEBSBIABKL-UHFFFAOYSA-N hexamethyldisilane Chemical compound C[Si](C)(C)[Si](C)(C)C NEXSMEBSBIABKL-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229940040461 lipase Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000005055 methyl trichlorosilane Substances 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- JLUFWMXJHAVVNN-UHFFFAOYSA-N methyltrichlorosilane Chemical compound C[Si](Cl)(Cl)Cl JLUFWMXJHAVVNN-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005053 propyltrichlorosilane Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229950000112 serrapeptase Drugs 0.000 description 1
- 108010038132 serratiopeptidase Proteins 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- ZOYFEXPFPVDYIS-UHFFFAOYSA-N trichloro(ethyl)silane Chemical compound CC[Si](Cl)(Cl)Cl ZOYFEXPFPVDYIS-UHFFFAOYSA-N 0.000 description 1
- LFXJGGDONSCPOF-UHFFFAOYSA-N trichloro(hexyl)silane Chemical compound CCCCCC[Si](Cl)(Cl)Cl LFXJGGDONSCPOF-UHFFFAOYSA-N 0.000 description 1
- DOEHJNBEOVLHGL-UHFFFAOYSA-N trichloro(propyl)silane Chemical compound CCC[Si](Cl)(Cl)Cl DOEHJNBEOVLHGL-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は塗擦により液化する
粉末化粧料に関する。さらに詳しくは、使用時に塗擦す
ると液化して乳液様の特性が生じる粉末化粧料であっ
て、きしみ感がなく、きわめて良好な使用感および仕上
がりを得ることができるとともに、製品の長期保存性に
も優れ、さらに、水の存在下で不安定な成分や、水に溶
解した状態で製品の物性に悪影響を及ぼしたりする成分
(以下、「水存在下不安定成分」と総称)を配合した場
合でも、これら成分を安定に配合し、該成分の機能を十
分に発揮し得る粉末化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a powder cosmetic which is liquefied by rubbing. More specifically, it is a powder cosmetic that liquefies when applied during use and produces an emulsion-like property, and has no squeaky feeling, can provide a very good feeling of use and finish, and also has a long shelf life of the product. Excellent, and even when components that are unstable in the presence of water or components that adversely affect the physical properties of the product when dissolved in water (hereinafter collectively referred to as “unstable components in the presence of water”) The present invention relates to a powder cosmetic which can stably blend these components and sufficiently exhibit the function of the components.
【0002】[0002]
【従来の技術】従来、いわゆるドライウォーターと称さ
れる粉末化粧料では、水や水性成分を、疎水化処理した
粉末等で被覆して粉末化し、使用時に塗擦すると液化す
るようになされている。これら粉末化粧料として、白
粉、美白パウダー等が知られているが、仕上がりが粉っ
ぽく、肌が乾燥しやすい等の問題があった。2. Description of the Related Art Conventionally, in the case of powder cosmetics called so-called dry water, water or an aqueous component is coated with a hydrophobized powder or the like to form a powder, which is liquefied when rubbed when used. As these powder cosmetics, white powder, whitening powder, and the like are known, but there are problems such as a finished powdery and easily dried skin.
【0003】また、一般に化粧料には、薬剤など種々の
有効成分が配合されているが、この薬剤の肌への浸透性
促進、保湿性、エモリエント性の付与等を目的として、
粉末化粧料を水、油、液状化粧料等と混合して使用する
方法も行われているが、使用性などの点で問題があっ
た。さらに、この有効成分が、水の存在下で容易に分
解、変質するなど不安定で製品の物性に悪影響を及ぼし
たりするような場合、その配合は、化粧料の剤型のみな
らず、容器形態、保存条件、取り扱い等において種々の
制約を受ける。[0003] In general, various active ingredients such as drugs are blended in cosmetics. However, for the purpose of promoting the penetration of the drugs into the skin, moisturizing properties, imparting emollient properties, etc.
A method of mixing powder cosmetics with water, oil, liquid cosmetics and the like has also been used, but has a problem in usability and the like. Furthermore, when this active ingredient is easily decomposed or deteriorated in the presence of water and is unstable and adversely affects the physical properties of the product, the formulation is not limited to the cosmetic formulation but also to the container form. , Storage conditions, handling, etc.
【0004】このような問題に対処すべく種々の技術が
提案されている。例えば、特開平6−211620号公
報には、特定の表面積を有する疎水化無水ケイ酸、フッ
素化合物被覆処理化粧料粉体、油性成分、水性成分、お
よび不安定有効成分(水存在下不安定成分)を特定量配
合することによって、これら水存在下不安定成分の安定
な配合を図った粉末化粧料が開示されている。Various techniques have been proposed to address such a problem. For example, JP-A-6-21620 discloses a hydrophobized silicic acid anhydride having a specific surface area, a fluorine compound-coated cosmetic powder, an oily component, an aqueous component, and an unstable active component (unstable component in the presence of water). ) Is disclosed in a powder cosmetic in which the unstable component is stably blended in the presence of water by blending in a specific amount.
【0005】しかしながら、上記公報に記載の粉末化粧
料においては、油性成分配合のために、該油性成分をあ
らかじめフッ素化合物被覆処理化粧料粉末で粉末化処理
することが必要となり、製造工程が煩雑となる不具合が
ある。さらに使用性の点においても、配合されている疎
水化無水ケイ酸とフッ素化合物被覆処理化粧料粉体との
粉末特性に起因するきしみ感が生じるという問題があ
る。However, in the powder cosmetics described in the above-mentioned publications, it is necessary to powder the oily components with a fluorine compound-coated cosmetic powder in advance in order to mix the oily components, which makes the production process complicated. There is a problem. Further, in terms of usability, there is a problem that a squeaky feeling is caused due to the powder characteristics of the hydrophobized silicic acid compound and the fluorine compound-coated cosmetic powder.
【0006】[0006]
【発明が解決しようとする課題】本発明は上記事情に鑑
みてなされたもので、粉末形態の化粧料でありながら使
用時に塗擦すると液化して化粧水または乳液様の特性が
生じる粉末化粧料であって、油性成分を粉末化処理する
ことなく系中に配合することができ、きしみ感がなく、
きわめて良好な使用感および仕上がりを得ることができ
るとともに、製品の長期保存安定性にも優れ、さらに、
水存在下不安定成分を配合した場合でもこれら成分を安
定に配合し、それらの機能を十分に発揮し得る塗擦によ
り液化する粉末化粧料を提供することを目的とする。DISCLOSURE OF THE INVENTION The present invention has been made in view of the above circumstances, and is a powder cosmetic which is a powdery cosmetic which liquefies when rubbed at the time of use to produce a lotion or emulsion-like property while being used in powder form. There is no squeaky feeling because oily components can be blended into the system without powdering.
A very good feeling and finish can be obtained, and the product has excellent long-term storage stability.
An object of the present invention is to provide a powder cosmetic which is liquefied by rubbing, in which even if unstable components are mixed in the presence of water, these components are stably mixed and the functions thereof can be sufficiently exhibited.
【0007】[0007]
【課題を解決するための手段】本発明は、(a)表面積
60m2/g以上の疎水化無水ケイ酸と、(b)水中油
型乳化組成物を1種または2種以上とを含有し、塗擦に
より液化する粉末化粧料に関する。The present invention comprises (a) a hydrophobized silicic anhydride having a surface area of 60 m 2 / g or more, and (b) one or more oil-in-water emulsion compositions. And powder cosmetics that are liquefied by rubbing.
【0008】また本発明は、上記粉末化粧料にさらに
(c)水存在下不安定成分を含有する、塗擦により液化
する粉末化粧料に関する。The present invention also relates to a powder cosmetic which is liquefied by rubbing, wherein the powder cosmetic further comprises (c) an unstable component in the presence of water.
【0009】[0009]
【発明の実施の形態】以下、本発明について詳述する。
本発明に用いられる(a)成分としての疎水化無水ケイ
酸は、微粒子無水ケイ酸表面を疎水化処理したものであ
る。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail.
The hydrophobized silicic anhydride as the component (a) used in the present invention is obtained by hydrophobizing the surface of fine silica particles.
【0010】疎水化処理の方法としては、無水ケイ酸に
撥水性を付与できる方法であればいかなるものでもよ
く、その方法は問わないが、例えば気相法、液相法、オ
ートクレーブ法、メカノケミカル法等、通常の表面処理
方法を用いることができる。The method of the hydrophobizing treatment may be any method as long as it can impart water repellency to the silicic anhydride, and the method is not limited. Examples thereof include a gas phase method, a liquid phase method, an autoclave method, and a mechanochemical method. An ordinary surface treatment method such as a method can be used.
【0011】例えば疎水化処理剤を原料粉末に添加して
処理を行う場合、適当な溶媒(ジクロルメタン、クロロ
ホルム、ヘキサン、エタノール、キシレン、揮発性シリ
コーン等)に希釈して添加してもよく、あるいは直接添
加してもよい。粉末と処理剤の混合攪拌には、ボールミ
ル、ホジャーサイトボールミル、振動ボールミル、アト
ライター、ポットミル、ロッドミル、パンミル、ホモミ
キサー、ホモディスパー、ヘンシェルミキサー、ナウタ
ーミキサー等も使用することができる。この他にも、粉
末表面の活性を利用し、気相反応により100℃以下の
低温で環状オルガノシロキサンを粉末表面上で重合させ
る方法(特公平1−54380号)や、前記方法の後に
表面のシリコーンポリマーのSi−H部分にグリセロー
ルモノアリルエーテル等のペンダント基を付加させる方
法(特公平1−54381号)等も用いることができ
る。For example, when the treatment is carried out by adding a hydrophobizing agent to the raw material powder, the agent may be diluted with an appropriate solvent (dichloromethane, chloroform, hexane, ethanol, xylene, volatile silicone, etc.) and added. You may add directly. For mixing and stirring the powder and the treating agent, a ball mill, a Hogersight ball mill, a vibration ball mill, an attritor, a pot mill, a rod mill, a pan mill, a homomixer, a homodisper, a Henschel mixer, a Nauter mixer, and the like can also be used. In addition to this, a method of polymerizing a cyclic organosiloxane on a powder surface at a low temperature of 100 ° C. or less by a gas phase reaction utilizing the activity of the powder surface (Japanese Patent Publication No. 1-54380), A method of adding a pendant group such as glycerol monoallyl ether to the Si-H portion of the silicone polymer (Japanese Patent Publication No. 1-54381) can also be used.
【0012】疎水化処理剤としては、特に限定されるも
のではないが、脂肪酸デキストリン処理粉末、トリメチ
ルシロキシ珪酸処理粉末、フッ素変性トリメチルシロキ
シ珪酸処理粉末、メチルフェニルシロキシ珪酸処理粉
末、フッ素変性メチルフェニルシロキシ珪酸処理粉末、
ジメチルポリシロキサン、ジフェニルポリシロキサン、
メチルフェニルポリシロキサン等の低粘度〜高粘度油状
ポリシロキサン処理粉末、ガム状ポリシロキサン処理粉
末、メチルハイドロジェンポリシロキサン処理粉末、フ
ッ素変性メチルハイドロジェンポリシロキサン処理粉
末、メチルトリクロルシラン、メチルトリアルコキシシ
ラン、ヘキサメチルジシラン、ジメチルジクロルシラ
ン、ジメチルジアルコキシシラン、トリメチルクロルシ
ラン、トリメチルアルコキシシラン等の有機シリル化合
物あるいはそれらのフッ素置換体による処理粉末、エチ
ルトリクロルシラン、エチルトリアルコキシシラン、プ
ロピルトリクロルシラン、プロピルトリアルコキシシラ
ン、ヘキシルトリクロルシラン、ヘキシルトリアルコキ
シシラン、長鎖アルキルトリクロルシラン、長鎖アルキ
ルトリエトキシシラン等の有機変性シランあるいはそれ
らのフッ素置換体による処理粉末、アミノ変性ポリシロ
キサン処理粉末、フッ素変性ポリシロキサン処理粉末、
フッ化アルキルリン酸処理粉末等が挙げられる。The hydrophobizing agent is not particularly limited, but may be a fatty acid dextrin-treated powder, trimethylsiloxysilicate-treated powder, fluorine-modified trimethylsiloxysilicate-treated powder, methylphenylsiloxysilicate-treated powder, or fluorine-modified methylphenylsiloxy. Silicate treated powder,
Dimethyl polysiloxane, diphenyl polysiloxane,
Low-viscosity oily polysiloxane-treated powder such as methylphenylpolysiloxane, gum-like polysiloxane-treated powder, methylhydrogenpolysiloxane-treated powder, fluorine-modified methylhydrogenpolysiloxane-treated powder, methyltrichlorosilane, methyltrialkoxysilane Powder treated with an organic silyl compound such as hexamethyldisilane, dimethyldichlorosilane, dimethyldialkoxysilane, trimethylchlorosilane, trimethylalkoxysilane or a fluorine-substituted product thereof, ethyltrichlorosilane, ethyltrialkoxysilane, propyltrichlorosilane, Propyl trialkoxysilane, hexyl trichlorosilane, hexyl trialkoxysilane, long-chain alkyltrichlorosilane, long-chain alkyltriethoxysilane Organic modified silane or treated powder according to their fluorine substitution products, amino-modified polysiloxane treatment powder, fluorine-modified polysiloxane treatment powder,
Fluoroalkyl phosphoric acid-treated powder and the like.
【0013】本発明では、例えば微粒子無水ケイ酸の表
面をオルガノシラン系化合物、シリコーン化合物等で覆
うことにより調製することができる。具体的には、トリ
メチルシロキシル化無水ケイ酸、ジメチルシロキシル化
無水ケイ酸、オクチルシロキシル化無水ケイ酸、シリコ
ーンオイル処理無水ケイ酸、メチルポリシロキサン処理
無水ケイ酸等が例示される。In the present invention, it can be prepared, for example, by covering the surface of fine silica particles with an organosilane compound or a silicone compound. Specific examples include trimethylsiloxylated silicic anhydride, dimethylsiloxylated silicic anhydride, octylsiloxylated silicic anhydride, silicic anhydride treated with silicone oil, silicic anhydride treated with methylpolysiloxane, and the like.
【0014】本発明では、疎水化無水ケイ酸は表面積が
60m2/g以上であることが必要であり、表面積がこ
れより小さいと、疎水化無水ケイ酸の粒径が大きくな
り、(b)成分である水中油型乳化組成物の表面に多量
に配向することができず、水中油型乳化組成物を安定に
粉末化することが難しくなる。In the present invention, the hydrophobized silicic acid needs to have a surface area of 60 m 2 / g or more. If the surface area is smaller than this, the particle size of the hydrophobized silicic acid increases, and (b) It is not possible to orient a large amount on the surface of the oil-in-water emulsion composition as a component, and it becomes difficult to stably powder the oil-in-water emulsion composition.
【0015】(a)成分の配合量は、その上限が好まし
くは20重量%であり、特には10重量%である。また
その下限が好ましくは2重量%であり、特には5重量%
である。配合量が少なすぎると、(b)成分である水中
油型乳化組成物を十分に粉末化できず、意図する粉末形
態を得ることができなくなるおそれがあり、一方、配合
量が多すぎると、多量の水中油型乳化組成物を粉末化す
ることができるようにはなるが、使用時塗擦しても液化
が困難となり、官能上好ましくない。The upper limit of the amount of component (a) is preferably 20% by weight, especially 10% by weight. The lower limit is preferably 2% by weight, particularly 5% by weight.
It is. If the amount is too small, the oil-in-water emulsion composition as the component (b) cannot be sufficiently pulverized, and the intended powder form may not be obtained. On the other hand, if the amount is too large, Although a large amount of the oil-in-water emulsified composition can be powdered, liquefaction becomes difficult even when rubbed at the time of use, which is not preferred in terms of functionality.
【0016】(b)成分は、水相(外相)と油相(内
相)とを乳化してなる水中油型(O/W)乳化組成物の
1種または2種以上である。これらはきしみ感を解消し
良好な使用性を発揮させるための成分である。(b)成
分の乳化の型が油中水型(W/O)乳化の場合、(a)
成分の疎水性が強いため、外相の油性成分に膨潤してし
まい粉末形態をとることができなくなる。The component (b) is one or more oil-in-water (O / W) emulsified compositions obtained by emulsifying an aqueous phase (outer phase) and an oil phase (inner phase). These are components for eliminating the feeling of creaking and exhibiting good usability. (B) When the type of emulsification of the component is a water-in-oil type (W / O) emulsification,
Since the component has high hydrophobicity, it swells in the oily component of the external phase and cannot take a powder form.
【0017】(b)成分の水相(外相)には、一般に化
粧料に用いられ得る水性成分であれば特に限定されるも
のでなく、例えば精製水等の水、水溶性高分子等が好ま
しく用いられる。The aqueous phase (outer phase) of the component (b) is not particularly limited as long as it is an aqueous component generally usable in cosmetics. For example, water such as purified water, a water-soluble polymer and the like are preferable. Used.
【0018】水溶性高分子としては、例えば天然の水溶
性高分子、半合成の水溶性高分子、合成の水溶性高分
子、無機の水溶性高分子等が挙げられる。Examples of the water-soluble polymer include a natural water-soluble polymer, a semi-synthetic water-soluble polymer, a synthetic water-soluble polymer, and an inorganic water-soluble polymer.
【0019】天然の水溶性高分子としては、例えばアラ
ビアガム、トラガカントガム、ガラクタン、グアガム、
ローカストビンガム、キャロブガム、カラヤガム、カラ
ギーナン、ペクチン、マンナン、カンテン、クインスシ
ード(マルメロ)、アルゲコロイド(カッソウエキ
ス)、デンプン(コメ、トウモロコシ、バレイショ、コ
ムギ)、グリチルリチン酸等の植物系水溶性高分子;キ
サンタンガム、ヒアルロン酸、デキストラン、サクシノ
グルカン、カードラン、プルラン等の微生物系水溶性高
分子;コラーゲン、カゼイン、アルブミン、ゼラチン等
の動物系水溶性高分子等が挙げられる。Examples of natural water-soluble polymers include gum arabic, tragacanth gum, galactan, guar gum,
Plant-based water-soluble polymers such as locust bingham, carob gum, karaya gum, carrageenan, pectin, mannan, agar, quince seed (quince), alge colloid (grape extract), starch (rice, corn, potato, wheat), glycyrrhizic acid; xanthan gum , Hyaluronic acid, dextran, succinoglucan, curdlan, pullulan, etc .; and animal-based water-soluble polymers such as collagen, casein, albumin, gelatin and the like.
【0020】半合成の水溶性高分子としては、例えばカ
ルボキシメチルデンプン、メチルヒドロキシプロピルデ
ンプン等のデンプン系水溶性高分子;メチルセルロー
ス、ニトロセルロース、エチルセルロース、メチルヒド
ロキシプロピルセルロース、ヒドロキシエチルセルロー
ス、セルロース硫酸ナトリウム、ヒドロキシプロピルセ
ルロース、カルボキシメチルセルロースナトリウム(C
MC)、結晶セルロース、セルロース末等のセルロース
系水溶性高分子;アルギン酸ナトリウム、アルギン酸プ
ロピレングリコールエステル等のアルギン酸系水溶性高
分子等が挙げられる。The semi-synthetic water-soluble polymer includes, for example, starch-based water-soluble polymers such as carboxymethyl starch and methylhydroxypropyl starch; methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, cellulose sodium sulfate, Hydroxypropylcellulose, sodium carboxymethylcellulose (C
MC), cellulose-based water-soluble polymers such as crystalline cellulose and cellulose powder; and alginic acid-based water-soluble polymers such as sodium alginate and propylene glycol alginate.
【0021】合成の水溶性高分子としては、例えばポリ
ビニルアルコール、ポリビニルメチルエーテル、ポリビ
ニルピロリドン、カルボキシビニルポリマー(商品名
「カーボポール」)等のビニル系水溶性高分子;ポリエ
チレングリコール(分子量20,000、600,000、4,000,00
0)等のポリオキシエチレン系水溶性高分子;ポリオキ
シエチレンポリオキシプロピレン共重合体系水溶性高分
子;ポリアクリル酸ナトリウム、ポリエチルアクリレー
ト、ポリアクリルアミド等のアクリル系水溶性高分子;
ポリエチレンイミン、カチオンポリマー等が挙げられ
る。Examples of the synthetic water-soluble polymer include vinyl-based water-soluble polymers such as polyvinyl alcohol, polyvinyl methyl ether, polyvinylpyrrolidone, and carboxyvinyl polymer (trade name "Carbopol"); polyethylene glycol (molecular weight 20,000, 600,000). , 4,000,00
Polyoxyethylene-based water-soluble polymers such as 0); polyoxyethylene-polyoxypropylene copolymer-based water-soluble polymers; acrylic water-soluble polymers such as sodium polyacrylate, polyethyl acrylate, and polyacrylamide;
Examples thereof include polyethyleneimine and a cationic polymer.
【0022】無機の水溶性高分子としては、例えばベン
トナイト、ケイ酸AlMg(商品名「ビーガム」)、ラ
ポナイト、ヘクトライト等が挙げられる。Examples of the inorganic water-soluble polymer include bentonite, AlMg silicate (trade name "Vegum"), laponite, hectorite, and the like.
【0023】水相には、さらに保湿剤、キレート剤、植
物抽出液、アルコール、pH調整剤、防腐剤等を配合す
ることができる。The aqueous phase may further contain a humectant, a chelating agent, a plant extract, alcohol, a pH adjuster, a preservative, and the like.
【0024】保湿剤としては1,3−ブチレングリコー
ル、グリセリン等が例示される。Examples of the humectant include 1,3-butylene glycol, glycerin and the like.
【0025】キレート剤としては、メタリン酸塩、エデ
ト酸塩等が例示される。Examples of the chelating agent include metaphosphate and edetate.
【0026】植物抽出液としては、西洋ノコギリソウ抽
出液、ハマメリス抽出液等が例示される。Examples of the plant extract include a horseshoe extract and a hamamelis extract.
【0027】(b)成分の油相(内相)には、一般に化
粧料に用いられ得る油性成分であれば特に限定されるも
のでなく、例えばアボガド油、ツバキ油、タートル油、
マカデミアナッツ油、トウモロコシ油、ミンク油、オリ
ーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小
麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワ
ー油、綿実油、エノ油、大豆油、落花生油、茶実油、カ
ヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ
油、胚芽油、トリグリセリン、トリオクタン酸グリセリ
ン、テトラオクタン酸ペンタエリスリット、トリイソパ
ルミチン酸グリセリン等の液体油脂;カカオ脂、ヤシ
油、硬化ヤシ油、パーム油、パーム核油、モクロウ核
油、硬化油、モクロウ、硬化ヒマシ油等の固体油脂;ミ
ツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベ
イベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌ
カロウ、ラノリン、カポックロウ、酢酸ラノリン、液状
ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピ
ル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロ
ウ、硬質ラノリン、セラックロウ、POEラノリンアル
コールエーテル、POEラノリンアルコールアセテー
ト、POEコレステロールエーテル、ラノリン脂肪酸ポ
リエチレングリコール、POE水素添加ラノリンアルコ
ールエーテル等のロウ類;流動パラフィン、オゾケライ
ト、スクワレン、プリスタン、パラフィン、セレシン、
スクワラン、ワセリン、マイクロクリスタリンワックス
等の炭化水素油;ミリスチン酸イソプロピル、オクタン
酸セチル、ミリスチン酸オクチルドデシル、パルミチン
酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキ
シル、ミリスチン酸ミリスチル、オレイン酸デシル、ジ
メチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミ
リスチル、酢酸ラノリン、ステアリン酸イソセチル、イ
ソステアリン酸イソセチル、12−ヒドロキシステアリ
ル酸コレステリル、ジ−2−エチルヘキシル酸エチレン
グリコール、ジペンタエリスリトール脂肪酸エステル、
モノイソステアリン酸N−アルキルグリコール、ジカプ
リン酸ネオペンチルグリコール、リンゴ酸ジイソステア
リル、ジ−2−ヘプチルウンデカン酸グリセリン、トリ
−2−エチルヘキシル酸トリメチロールプロパン、トリ
イソステアリン酸トリメチロールプロパン、テトラ−2
−エチルヘキシル酸ペンタエリスリトール、トリー2−
エチルヘキシル酸グリセリン、トリイソステアリン酸ト
リメチロールプロパン、セチル2−エチルヘキサノエー
ト、2−エチルヘキシルパルミテート、トリミリスチン
酸グリセリン、トリ−2−ヘプチルウンデカン酸グリセ
ライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オ
イル、セトステアリルアルコール、アセトグリセライ
ド、パルミチン酸2−ヘプチルウンデシル、N−ラウロ
イル−L−グルタミン酸−2−オクチルドデシルエステ
ル、エチルラウレート、ミリスチン酸2−ヘキシルデシ
ル、パルミチン酸2−ヘキシルデシル、酢酸エチル、酢
酸ブチル、酢酸アミル、クエン酸トリエチル等の合成エ
ステル油;ジメチルポリシロキサン、メチルフェニルポ
リシロキサン、メチルハイドロジェンポリシロキサン等
の鎖状ポリシロキサン;オクタメチルシクロテトラシロ
キサン、デカメチルシクロペンタシロキサン、ドデカメ
チルシクロヘキサンシロキサン等の環状シリコーン等が
挙げられるが、これら例示に限定されるものでない。油
性成分は1種または2種以上を用いることができる。The oil phase (inner phase) of the component (b) is not particularly limited as long as it is an oily component that can be generally used in cosmetics. For example, avocado oil, camellia oil, turtle oil,
Macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, peanut oil, Liquid oils such as teaseed oil, kaya oil, rice bran oil, cinnamon oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin, glycerin trioctanoate, pentaerythritol tetraoctanoate, glycerin triisopalmitate; cocoa butter; Solid oils such as coconut oil, hydrogenated coconut oil, palm oil, palm kernel oil, molle kernel oil, hydrogenated oil, molle, hydrogenated castor oil, etc .; beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, whale wax, montan wax, nukarou , Lanolin, kapok wax, lanolin acetate, liquid lanolin, sugarcane Waxes such as isopropyl lanolin fatty acid, hexyl laurate, reduced lanolin, jojoba wax, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, and POE hydrogenated lanolin alcohol ether; Liquid paraffin, ozokerite, squalene, pristane, paraffin, ceresin,
Hydrocarbon oils such as squalane, petrolatum and microcrystalline wax; isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl dimethyl octanoate Decyl, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearate, ethylene glycol di-2-ethylhexylate, dipentaerythritol fatty acid ester,
N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, glycerin di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexylate, trimethylolpropane triisostearate, tetra-2
-Pentaerythritol ethylhexylate, tree 2-
Glycerin ethylhexylate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, glycerin trimyristate, glyceride tri-2-heptylundecanoate, methyl ester of castor oil fatty acid, oleic acid oil, seto Stearyl alcohol, acetoglyceride, 2-heptylundecyl palmitate, N-lauroyl-L-glutamic acid-2-octyldodecyl ester, ethyl laurate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, ethyl acetate, acetic acid Synthetic ester oils such as butyl, amyl acetate, and triethyl citrate; linear polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, and methylhydrogenpolysiloxane ; Octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, although cyclic silicones such as dodecamethyl cyclohexane siloxane, are not limited to these examples. One or more oil components can be used.
【0028】油相にはさらに、有機変性粘土鉱物、デン
プン脂肪酸エステル、ジメチルポリシロキサン重合物等
の油性ゲル化剤等を併用してもよい。さらに油性成分と
して、マイクロクリスタリンワックス等の高融点ワック
スを微粉末化したものや、炭酸マグネシウム等の多孔質
粉体、アクリレートコポリマー等の高凝集性ポリマー等
に油性成分を担持吸収させ、粉末化したもの、ポリメチ
ルメタクリレート、硬化ゼラチン、寒天等で油性成分を
カプセル化したもの等を用いることもできる。The oil phase may further contain an oily gelling agent such as an organically modified clay mineral, a starch fatty acid ester, or a dimethylpolysiloxane polymer. Further, as an oily component, a fine powder of a high melting point wax such as a microcrystalline wax, a porous powder such as magnesium carbonate, a highly cohesive polymer such as an acrylate copolymer, etc., carry and absorb the oily component, and are powdered. And those obtained by encapsulating an oily component with polymethyl methacrylate, hardened gelatin, agar, or the like.
【0029】特に、油性成分をカプセル化したものを用
いることにより、(i)多種類の油分を配合して化粧料
の使用性を調節、改善することができる、(ii)油溶性
薬剤、香料等をカプセル内に包含させることにより、塗
擦使用時まで安定して薬剤成分、香料成分を持続させる
ことができる、等の効果がある。In particular, the use of encapsulated oily components allows (i) the use of cosmetics to be adjusted and improved by blending various kinds of oils, and (ii) oil-soluble drugs and fragrances. Including capsules and the like in the capsule has effects such as stabilizing the drug component and the fragrance component until the time of rubbing use.
【0030】カプセル化成分としては、具体的にはゼラ
チン、寒天、アルギン酸ナトリウム、アガロース、ロジ
ン、アラビアゴム、エポキシ、ポリアクリルアミド、シ
ェラック、カルボキシメチルセルロース、ポリビニルア
ルコール、ポリウレタン、ポリスチレン、ポリエステ
ル、ポリアミド、ウレア等が好ましいものとして例示さ
れる。Specific examples of the encapsulated component include gelatin, agar, sodium alginate, agarose, rosin, gum arabic, epoxy, polyacrylamide, shellac, carboxymethylcellulose, polyvinyl alcohol, polyurethane, polystyrene, polyester, polyamide, and urea. Are exemplified as preferred.
【0031】カプセル内に包含される油成分としては、
化粧品に配合可能な油分であれば特に限定されることな
く用いることができるが、レチノール、酢酸トコフェロ
ール、l−メントール、ヒノキチオール、エチニルエス
トラジオール、オリーブ油等の油溶性薬剤成分や、香料
等を配合することにより、その有効成分を塗擦使用時ま
で安定的に持続させることができる。これら油成分は1
種または2種以上を用いることができる。As the oil component contained in the capsule,
Any oil component that can be blended in cosmetics can be used without any particular limitation, but it is possible to blend oil-soluble drug components such as retinol, tocopherol acetate, l-menthol, hinokitiol, ethinyl estradiol, olive oil, and flavors. Thereby, the active ingredient can be stably maintained until the time of use by rubbing. These oil components are 1
Species or two or more can be used.
【0032】油成分のカプセル化は、例えばコアセルベ
ーション法(特開平1−266846号、等)など、公
知の方法を用いて製造することができる。The oil component can be encapsulated by a known method such as a coacervation method (Japanese Patent Application Laid-Open No. Hei 1-266846, etc.).
【0033】(b)成分にはさらに、水中油型の乳化安
定性のより一層の向上のために、高級アルコール、高級
脂肪酸の他に、アクリル酸・メタクリル酸アルキル共重
合体、N−ステアロイル−L−グルタミン酸ナトリウム
等の高分子化合物を配合してもよい。The component (b) further includes, in addition to higher alcohols and higher fatty acids, an acrylic acid / alkyl methacrylate copolymer, N-stearoyl- A polymer compound such as sodium L-glutamate may be blended.
【0034】高級アルコールとしては、例えばセチルア
ルコール、ステアリルアルコール、イソステアリルアル
コール、2−オクチルドデカノール、ベヘニルアルコー
ル等が挙げられる。Examples of the higher alcohol include cetyl alcohol, stearyl alcohol, isostearyl alcohol, 2-octyldodecanol, and behenyl alcohol.
【0035】高級脂肪酸としては、例えばパルミチン
酸、ステアリン酸、ベヘン(ベヘニン)酸、オレイン
酸、12−ヒドロキシステアリン酸、イソステアリン
酸、リノール酸、リノレイン酸、エイコサペンタエン酸
(EPA)、ドコサヘキサエン酸(DHA)等が挙げら
れる。As higher fatty acids, for example, palmitic acid, stearic acid, behenic (behenic) acid, oleic acid, 12-hydroxystearic acid, isostearic acid, linoleic acid, linoleic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) ) And the like.
【0036】(b)成分のO/W乳化組成物は、常法に
より調製することができ、乳化の方法は特に限定される
ものでない。例えば、油相と水相を、それぞれ70℃程
度に加温し、加温した水相を油相に徐々に添加して、乳
化機で乳化し、その後、室温まで放冷する等の方法が挙
げられるが、これに限定されるものでない。特に、アク
リル酸・メタクリル酸アルキル共重合体、N−ステアロ
イル−L−グルタミン酸ナトリウム等の高分子、あるい
は高級アルコール/高給脂肪酸の組み合わせを用いて乳
化を行って得たO/W乳化組成物を(a)成分で粉末化
した粉末化粧料は、優れた使用性を有する。The O / W emulsion composition of the component (b) can be prepared by a conventional method, and the emulsification method is not particularly limited. For example, a method in which an oil phase and an aqueous phase are each heated to about 70 ° C., the heated aqueous phase is gradually added to the oil phase, emulsified by an emulsifier, and then allowed to cool to room temperature. But not limited thereto. In particular, an O / W emulsion composition obtained by emulsification using a polymer such as an acrylic acid / alkyl methacrylate copolymer, a polymer such as sodium N-stearoyl-L-glutamate, or a combination of a higher alcohol and a high-supply fatty acid is used. The powder cosmetic powdered with the component (a) has excellent usability.
【0037】(b)成分の配合量は、本発明化粧料に含
まれる他の必須成分、任意添加成分の総配合量の残量分
配合することができるが、本発明では、その上限が好ま
しくは98重量%であり、特には90重量%であり、ま
た、その下限が好ましくは80重量%であり、特には8
5重量%である。配合量が少なすぎると塗擦した時に液
化が困難となり、一方、配合量が多すぎると粉末化が難
しくなり、官能上好ましくない。The amount of the component (b) can be mixed with the remaining amount of the total amount of the other essential components and optional components contained in the cosmetic of the present invention. In the present invention, the upper limit is preferably used. Is 98% by weight, particularly 90% by weight, and the lower limit thereof is preferably 80% by weight, particularly 8% by weight.
5% by weight. If the amount is too small, liquefaction becomes difficult when rubbing, while if the amount is too large, powdering becomes difficult, which is not preferred in terms of functionality.
【0038】上記(a)、(b)成分を必須成分として
含有する本発明粉末化粧料は、従来、粉末化粧料に特有
の不具合とされていたきしみ感を軽減させ、使用性の点
において優れた効果が得られる。また粉末化が良好で、
塗擦時に容易に液化し、みずみずしい使用感を与える。The powder cosmetic of the present invention containing the above-mentioned components (a) and (b) as essential components reduces the feeling of creaking, which has hitherto been considered a problem peculiar to powder cosmetics, and is excellent in usability. The effect is obtained. Also good powdering,
It liquefies easily during rubbing and gives a fresh feeling of use.
【0039】本発明では、上記(a)、(b)成分に加
えて、さらに(c)成分として水存在下不安定成分を配
合してもよい。In the present invention, in addition to the components (a) and (b), an unstable component in the presence of water may be further added as the component (c).
【0040】(c)成分としての水存在下不安定成分
は、例えば、化粧料、医薬品等に薬剤等として配合さ
れ、その機能を発揮するためには水の介在が不可欠であ
る水溶性の成分であるが、水との接触、光、熱等の影響
により分解、失活、結晶析出、変退色、異臭を生じる
等、水の存在下で不安定で、そのまま水性ないし乳化型
化粧料に配合すると分離、凝集、増粘等を生じさせるも
のをいう。このような成分としては、例えば、美白剤、
抗炎症剤、抗菌剤、ホルモン剤、ビタミン類、酵素、抗
酸化剤、植物抽出液などの薬剤が挙げられる。The unstable component in the presence of water as the component (c) is, for example, a water-soluble component which is blended as a drug or the like in cosmetics, pharmaceuticals, etc., and in which the intervention of water is indispensable to exhibit its function. However, it is unstable in the presence of water, such as decomposition, inactivation, crystal precipitation, discoloration, and off-odor due to the effects of contact with water, light, heat, etc. Then, it refers to one that causes separation, aggregation, thickening, and the like. Such components include, for example, whitening agents,
Examples of such agents include anti-inflammatory agents, antibacterial agents, hormonal agents, vitamins, enzymes, antioxidants, and plant extracts.
【0041】美白剤としては、アルブチン等のハイドロ
キノン誘導体、コウジ酸、L−アスコルビン酸およびそ
の誘導体、パントテニールエチルエーテル、トラネキサ
ム酸およびその誘導体などが例示される。Examples of the whitening agent include hydroquinone derivatives such as arbutin, kojic acid, L-ascorbic acid and its derivatives, pantotenyl ethyl ether, tranexamic acid and its derivatives.
【0042】L−アスコルビン酸は、一般にビタミンC
といわれ、その強い還元作用により細胞呼吸作用、酵素
賦活作用、膠原形成作用を有し、かつメラニン還元作用
を有する。L−アスコルビン酸誘導体としては、例えば
L−アスコルビン酸モノリン酸エステル、L−アスコル
ビン酸−2−硫酸エステルなどのL−アスコルビン酸モ
ノエステル類や、L−アスコルビン酸−2−グルコシド
などのL−アスコルビン酸グルコシド類、あるいはこれ
らの塩などが挙げられる。L-ascorbic acid generally contains vitamin C
It is said that it has a cell respiratory action, an enzyme activating action, a collagen formation action and a melanin reducing action by its strong reducing action. Examples of L-ascorbic acid derivatives include L-ascorbic acid monoesters such as L-ascorbic acid monophosphate and L-ascorbic acid-2-sulfate, and L-ascorbic acid such as L-ascorbic acid-2-glucoside. Acid glucosides, or salts thereof, and the like.
【0043】トラネキサム酸誘導体としては、トラネキ
サム酸の二量体(例えば、塩酸トランス−4−(トラン
ス−アミノメチルシクロヘキサンカルボニル)アミノメ
チルシクロヘキサンカルボン酸、等)、トラネキサム酸
とハイドロキノンのエステル体(例えば、トランス−4
−アミノメチルシクロヘキサンカルボン酸4’−ヒドロ
キシフェニルエステル、等)、トラネキサム酸とゲンチ
シン酸のエステル体(例えば、2−(トランス−4−ア
ミノメチルシクロヘキシルカルボニルオキシ)−5−ヒ
ドロキシ安息香酸およびその塩、等)、トラネキサム酸
のアミド体(例えば、トランス−4−アミノメチルシク
ロヘキサンカルボン酸メチルアミドおよびその塩、トラ
ンス−4−(P−メトキシベンゾイル)アミノメチルシ
クロヘキサンカルボン酸およびその塩、トランス−4−
グアニジノメチルシクロヘキサンカルボン酸およびその
塩、等)などが挙げられる。Examples of the tranexamic acid derivative include tranexamic acid dimers (for example, trans-4- (trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid, etc.) and esters of tranexamic acid and hydroquinone (for example, Transformer-4
-Aminomethylcyclohexanecarboxylic acid 4'-hydroxyphenyl ester, etc.), esters of tranexamic acid and gentisic acid (e.g., 2- (trans-4-aminomethylcyclohexylcarbonyloxy) -5-hydroxybenzoic acid and salts thereof, Tranexamic acid amides (eg, trans-4-aminomethylcyclohexanecarboxylic acid methylamide and its salts, trans-4- (P-methoxybenzoyl) aminomethylcyclohexanecarboxylic acid and its salts, trans-4-
Guanidinomethylcyclohexanecarboxylic acid and its salts, etc.).
【0044】抗炎症剤としては、例えばグリチルリチン
酸塩(例えばグリチルリチン酸ジカリウム、グリチルリ
チン酸アンモニウム、等)、アラントインなどが挙げら
れる。Examples of the anti-inflammatory agent include glycyrrhizinate (eg, dipotassium glycyrrhizinate, ammonium glycyrrhizinate, etc.), allantoin and the like.
【0045】抗菌剤としては、例えばレゾルシン、イオ
ウ、サリチル酸などが挙げられる。Examples of the antibacterial agent include resorcin, sulfur, salicylic acid and the like.
【0046】ホルモン剤としては、例えばオキシトシ
ン、コルチコトロピン、バソプレッシン、セクレチン、
ガストリン、カルシトニンなどが挙げられる。Hormonal agents include, for example, oxytocin, corticotropin, vasopressin, secretin,
Gastrin, calcitonin and the like.
【0047】ビタミン類としては、例えばビタミン
B6、ビタミンB6塩酸塩等のビタミンB 6誘導体、ニコ
チン酸、ニコチン酸アミド等のニコチン酸誘導体などが
挙げられる。As the vitamins, for example, vitamins
B6, Vitamin B6Vitamin B such as hydrochloride 6Derivative, Nico
Nicotinic acid derivatives such as formic acid and nicotinamide
No.
【0048】酵素としては、例えばトリプシン、塩化リ
ゾチーム、キモトリプシン、セミアルカリプロテナー
ゼ、セラペプターゼ、リパーゼ、ヒアルロニダーゼなど
が挙げられる。Examples of the enzyme include trypsin, lysozyme chloride, chymotrypsin, semi-alkaline proteinase, serrapeptase, lipase, hyaluronidase and the like.
【0049】抗酸化剤としては、チオタウリン、グルタ
チオン、カテキン、アルブミン、フェリチン、メタロチ
オネインなどが挙げられる。The antioxidants include thiotaurine, glutathione, catechin, albumin, ferritin, metallothionein and the like.
【0050】植物抽出液としては、茶エキス、イザヨイ
バラエキス、オウゴンエキス、ドクダミエキス、オウバ
クエキス、メリロートエキス、オドリコソウエキス、カ
ンゾウエキス、シャクヤクエキス、サボンソウエキス、
ヘチマエキス、キナエキス、ユキノシタエキス、クララ
エキス、コウホネエキス、ウイキョウエキス、サクラソ
ウエキス、バラエキス、ジオウエキス、レモンエキス、
シコンエキス、アロエエキス、ショウブ根エキス、ユー
カリエキス、スギナエキス、セージエキス、タイムエキ
ス、海藻エキス、キューカンバエキス、チョウジエキ
ス、キイチゴエキス、メリッサエキス、ニンジンエキ
ス、マロニエエキス、モモエキス、桃葉エキス、クワエ
キス、ヤグルマギクエキス、ハマメリスエキス、カンゾ
ウエキスなどが挙げられる。[0050] Plant extracts include tea extract, Izayobara extract, Japanese gourd extract, Budwort extract, Ouba extract, melilot extract, Oyster extract, Licorice extract, Peony extract, Sabonso extract,
Loofah extract, kina extract, saxifrage extract, clara extract, kohone extract, fennel extract, primrose extract, rose extract, gyno extract, lemon extract,
Chicken extract, aloe extract, shobu root extract, eucalyptus extract, horsetail extract, sage extract, thyme extract, seaweed extract, cucumber extract, clove extract, raspberry extract, melissa extract, carrot extract, maroni extract, peach extract, peach extract, mulberry extract, cornflower Extract, hamamelis extract, licorice extract and the like.
【0051】(c)成分の配合量は、その上限が10重
量%が好ましく、より好ましくは7重量%であり、特に
は5重量%である。またその下限が0.001重量%が
好ましく、より好ましくは0.005重量%であり、特
には0.01重量%である。配合量が少なすぎると、有
効成分たる(c)成分の機能を十分に発揮することが難
しく、一方、配合量が必要以上に多すぎても、配合量の
増加に見合った効果の増強を見込むことが困難となる。
本発明粉末化粧料では、(c)成分を配合した場合で
も、これら成分の安定化を図ることができ、それらの機
能を十分に発揮し得る。The upper limit of the amount of component (c) is preferably 10% by weight, more preferably 7% by weight, and particularly preferably 5% by weight. The lower limit is preferably 0.001% by weight, more preferably 0.005% by weight, and particularly 0.01% by weight. If the amount is too small, it is difficult to sufficiently exert the function of the active ingredient (c). On the other hand, if the amount is too large, the effect is expected to increase in proportion to the increase in the amount. It becomes difficult.
In the powder cosmetic of the present invention, even when the component (c) is blended, these components can be stabilized, and their functions can be sufficiently exhibited.
【0052】本発明の粉末化粧料には、上記成分以外
に、通常の化粧料に用いられる各種の任意成分、例え
ば、香料、防腐剤、各種粉末、水溶性および油溶性薬剤
等を、本発明の効果を妨げない範囲で配合することがで
きる。The powder cosmetic of the present invention may contain, in addition to the above-mentioned components, various optional ingredients used in ordinary cosmetics, such as fragrances, preservatives, various powders, water-soluble and oil-soluble drugs, and the like. Can be blended within a range that does not hinder the effect of the above.
【0053】本発明化粧料は、粉末の化粧料であるが、
塗擦により液化するものであり、きしみ感がなく、きわ
めて良好な使用性を示し、また長期安定性にも優れ、か
つ水存在下不安定成分を安定に保持することができる。The cosmetic of the present invention is a powder cosmetic.
It liquefies by rubbing, has no squeaky feeling, shows extremely good usability, has excellent long-term stability, and can stably retain unstable components in the presence of water.
【0054】本発明の粉末化粧料は、(a)成分によ
り、(b)成分、さらには(c)成分の周りに吸着した
状態となってこれら(b)成分、(c)成分を粉末化し
たものであり、塗擦により力を加えると、この吸着状態
が破壊され、粉末化されていた(b)成分、(c)成分
がにじみ出て液化するとともに、(b)成分の添加効果
である使用感触の向上、および(c)成分の有効性が発
揮されるものである。The powder cosmetic of the present invention is adsorbed around the component (b) and the component (c) by the component (a), and these components (b) and (c) are powdered. When a force is applied by rubbing, this adsorbed state is destroyed, and the powdered components (b) and (c) ooze out and liquefy, and the addition effect of the component (b) is used. This improves the feel and the effectiveness of the component (c).
【0055】本発明の粉末化粧料は、(a)成分により
(b)成分、(c)成分を粉末化するものであれば特に
その製造方法は限定されるものでない。例えば、(b)
成分、あるいはここにさらに(c)成分を溶解したもの
に(a)成分を添加、混合する、等の製造方法が挙げら
れるが、これら例示に限定されるものではない。The method for producing the powder cosmetic of the present invention is not particularly limited as long as the component (b) and the component (c) are powdered with the component (a). For example, (b)
The production method includes, for example, adding and mixing the component (a) to the component or a solution obtained by further dissolving the component (c) therein, but is not limited thereto.
【0056】[0056]
【実施例】以下、本発明を実施例に基づきさらに詳細に
説明するが、本発明は以下の実施例に限定されるもので
はない。なお、配合量はすべて重量%で示す。EXAMPLES Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to the following examples. In addition, all compounding amounts are shown by weight%.
【0057】実施例に先立ち、本発明で用いた試験法お
よび評価法を説明する。Prior to the examples, test methods and evaluation methods used in the present invention will be described.
【0058】[使用性(きしみ感)試験]各実施例品、
比較例品の使用性(きしみ感)をパネル(50名)の実
使用試験によって下記基準により判定、評価した。 (判定基準) 著効: きしまない 有効: わずかにきしむが、使用上問題のない程度であ
る やや有効: きしむ 無効: 著しくきしむ (評価) ◎: 著効、有効、およびやや有効の判定をした被験者
が80%以上 ○: 著効、有効、およびやや有効の判定をした被験者
が50〜80%未満 △: 著効、有効、およびやや有効の判定をした被験者
が30〜50%未満 ×: 著効、有効、およびやや有効の判定をした被験者
が30%未満[Usability (squeaking feeling) test]
Usability (squeaking feeling) of the comparative example product was determined and evaluated by an actual use test of the panel (50 persons) according to the following criteria. (Judgment criteria) Significant effect: Not squeaky Effective: Slightly squeaked, but no problem in use Slightly effective: Squeaky Ineffective: Severe squealing (Evaluation) ◎: Significant effect, effective, and slightly effective 80% or more of the test subjects ○: 50 to less than 80% of subjects judged to be highly effective, effective, and slightly effective Δ: 30 to less than 50% of subjects judged to be extremely effective, effective, and slightly effective ×: Excellent Less than 30% of subjects judged effective, effective, and somewhat effective
【0059】[薬剤(水存在下不安定成分)安定性試
験]各実施例品について、40℃で保存(1ヵ月、3ヵ
月、6ヵ月)したときの水存在下不安定成分の残存量
を、HPLCにより測定し、これから残存率を調べた。[Stability Test of Drug (Unstable Component in the Presence of Water)] For each of the products of Examples, the residual amount of the unstable component in the presence of water when stored at 40 ° C. (one month, three months, six months) was determined. , HPLC, and the residual ratio was determined.
【0060】[製品の長期保存安定性試験]各実施例品
を、0℃、室温、露光条件(日光照射)下、40℃で6
ヵ月間保存したサンプルについて下記基準により評価し
た。 (評価) ◎: 化粧料は変化しなかった ○: 容器に粉末または水滴が若干付着した △: 若干離水を起こした ×: 離水が著しく製剤破壊が起こった[Product Long-Term Storage Stability Test] Each of the products of the Examples was prepared at 0 ° C., room temperature, and 40 ° C. under exposure conditions (sunshine irradiation).
The samples stored for months were evaluated according to the following criteria. (Evaluation) :: Cosmetic did not change. 粉末: Powder or water droplets slightly adhered to the container. △: Slightly water-separated.
【0061】(実施例1、比較例1)下記表1に示す組
成で粉末化粧料を調製した。上記試験方法により、実施
例1、比較例1の使用性(きしみ感)を評価した。な
お、表1中、トリメチルシリル基処理無水ケイ酸
(*)は、「アエロジルR812S」(日本アエロジル社
製;表面積220m2/g)を用いた。結果を表1に示
す。(Example 1, Comparative Example 1) Powder cosmetics were prepared according to the composition shown in Table 1 below. The usability (squeaking feeling) of Example 1 and Comparative Example 1 was evaluated by the above test method. In Table 1, trimethylsilyl group-treated silicic anhydride was used.
(*) Used "Aerosil R812S" (manufactured by Nippon Aerosil Co., Ltd .; surface area 220 m 2 / g). Table 1 shows the results.
【0062】[0062]
【表1】 [Table 1]
【0063】(製法)実施例1では、(1)〜(7)、
(9)を混合、溶解した(A相)。一方、これとは別に
(8)、(10)、(11)を混合、溶解した(B
相)。次いでB相をA相に徐々に添加しながら乳化物を
調製した。得られた乳化物と(12)を混合、攪拌し、
容器に充填した。(Manufacturing method) In Example 1, (1) to (7)
(9) was mixed and dissolved (phase A). On the other hand, (8), (10) and (11) were separately mixed and dissolved (B
phase). Next, an emulsion was prepared while gradually adding the phase B to the phase A. The obtained emulsion and (12) are mixed and stirred,
The container was filled.
【0064】一方、比較例1では、(1)〜(7)を混
合、溶解し、これと(12)を混合、攪拌し、容器に充
填した。On the other hand, in Comparative Example 1, (1) to (7) were mixed and dissolved, and this and (12) were mixed, stirred and filled in a container.
【0065】表1の結果より明らかなように、実施例1
の粉末化粧料は、比較例1に比べきしみ感が現れず、き
わめて良好な使用性を示した。As is clear from the results in Table 1, Example 1
The powdery cosmetic did not show a squeaky feeling as compared with Comparative Example 1, and showed extremely good usability.
【0066】(実施例2、比較例2)下記表2に示す組
成で粉末化粧料を調製した。上記試験方法により、実施
例2、比較例2の使用性(きしみ感)を評価した。な
お、表2中、ジメチルシリコーンオイル処理無水ケイ酸
(*)は、「アエロジルR202」(日本アエロジル社
製;表面積100m2/g)を用いた。結果を表2に示
す。(Example 2, Comparative Example 2) Powder cosmetics having the compositions shown in Table 2 below were prepared. The usability (squeaking feeling) of Example 2 and Comparative Example 2 was evaluated by the above test method. In Table 2, dimethylsilicone oil treated silicic anhydride was used.
(*) Used "Aerosil R202" (manufactured by Nippon Aerosil Co., Ltd .; surface area 100 m 2 / g). Table 2 shows the results.
【0067】[0067]
【表2】 [Table 2]
【0068】(製法)実施例2では、(1)〜(7)を
混合、溶解した(A相)。一方、これとは別に(8)〜
(14)を混合、溶解した(B相)。次いでB相をA相
に徐々に添加しながら乳化物を調製した。得られた乳化
物と(15)を混合、攪拌し、容器に充填した。(Production Method) In Example 2, (1) to (7) were mixed and dissolved (phase A). On the other hand, apart from this (8) ~
(14) was mixed and dissolved (phase B). Next, an emulsion was prepared while gradually adding the phase B to the phase A. The obtained emulsion and (15) were mixed, stirred, and filled in a container.
【0069】一方、比較例2では、(1)〜(7)を混
合、溶解し、これと(15)を混合、攪拌し、容器に充
填した。On the other hand, in Comparative Example 2, (1) to (7) were mixed and dissolved, and this and (15) were mixed, stirred and filled in a container.
【0070】表2の結果より明らかなように、実施例2
の粉末化粧料は、比較例2に比べきしみ感が現れず、き
わめて良好な使用性を示した。As is clear from the results in Table 2, Example 2
The powdery cosmetic did not show a squeaky feeling as compared with Comparative Example 2, and showed extremely good usability.
【0071】(実施例3、比較例3)下記表3に示す組
成で粉末化粧料を調製した。上記試験方法により、実施
例3、比較例3の使用性(きしみ感)を評価した。な
お、表3中、ジメチルシリコーンオイル処理無水ケイ酸
(*)は、「アエロジルRY200S」(日本アエロジル
社製;表面積80m2/g)を用いた。結果を表3に示
す。(Example 3, Comparative Example 3) Powder cosmetics having the compositions shown in Table 3 below were prepared. The usability (squeaking feeling) of Example 3 and Comparative Example 3 was evaluated by the above test method. In Table 3, dimethyl silicone oil treated silicic anhydride
(*) Used "Aerosil RY200S" (manufactured by Nippon Aerosil Co., Ltd .; surface area 80 m 2 / g). Table 3 shows the results.
【0072】[0072]
【表3】 [Table 3]
【0073】(製法)実施例3では、(1)〜(6)、
(8)を混合、溶解した(A相)。一方、これとは別に
(7)、(9)、(10)を混合、溶解した(B相)。
次いでB相をA相に徐々に添加しながら乳化物を調製し
た。得られた乳化物と(11)を混合、攪拌し、容器に
充填した。(Production method) In Example 3, (1) to (6)
(8) was mixed and dissolved (phase A). Separately, (7), (9), and (10) were mixed and dissolved (B phase).
Next, an emulsion was prepared while gradually adding the phase B to the phase A. The obtained emulsion and (11) were mixed, stirred, and filled in a container.
【0074】一方、比較例3では、(1)〜(6)を混
合、溶解し、これと(11)を混合、攪拌し、容器に充
填した。On the other hand, in Comparative Example 3, (1) to (6) were mixed and dissolved, and this and (11) were mixed, stirred and filled in a container.
【0075】表3の結果より明らかなように、実施例3
の粉末化粧料は、比較例3に比べきしみ感が現れず、き
わめて良好な使用性を示した。As is clear from the results in Table 3, Example 3
No powder cosmetics showed a squeaky feeling as compared with Comparative Example 3 and showed extremely good usability.
【0076】〈薬剤(水存在下不安定成分)の安定性〉
実施例1〜3で調製した本発明粉末化粧料について、上
記した薬剤(水存在下不安定成分)安定性試験方法によ
り、水存在下不安定成分の安定性を評価した。結果を表
4に示す。<Stability of Drug (Unstable Component in the Presence of Water)>
With respect to the powder cosmetics of the present invention prepared in Examples 1 to 3, the stability of the unstable component in the presence of water was evaluated by the above-described drug (unstable component in the presence of water) stability test method. Table 4 shows the results.
【0077】[0077]
【表4】 [Table 4]
【0078】表4から明らかなように、実施例1〜3の
粉末化粧料のいずれにおいても、40℃で6ヵ月経過後
も不安定有効成分がほとんど残存しており、経時の薬剤
安定性において問題のないものであった。As is evident from Table 4, in all of the powder cosmetics of Examples 1 to 3, unstable active ingredients almost remained even after elapse of 6 months at 40 ° C. There was no problem.
【0079】〈製品の長期保存安定性〉実施例1〜3で
調製した本発明粉末化粧料について、上記した長期保存
安定性試験方法により製品の長期保存安定性を評価し
た。結果を表5に示す。<Long-term storage stability of product> The long-term storage stability of the product was evaluated by the above-mentioned long-term storage stability test method for the powder cosmetics of the present invention prepared in Examples 1 to 3. Table 5 shows the results.
【0080】[0080]
【表5】 [Table 5]
【0081】表5から明らかなように、実施例1〜3の
粉末化粧料のいずれにおいても、各保存条件下で6ヵ月
経過後も製剤の形態がほとんど変化なく、経時の製品保
存安定性において問題のないものであった。As is evident from Table 5, in each of the powder cosmetics of Examples 1 to 3, the morphology of the preparation hardly changed even after 6 months under each storage condition, and the storage stability of the product over time was not changed. There was no problem.
【0082】 (実施例4) (配 合 成 分) (重量%) (1)キサンタンガム 0.3 (2)1,3−ブチレングリコール 4.0 (3)クエン酸 0.05 (4)クエン酸ナトリウム 0.05 (5)防腐剤 0.2 (6)水酸化カリウム 0.02 (7)精製水 残 余 (8)L−アスコルビン酸−2−グルコシド 1.0 (9)アクリル酸・メタクリル酸アルキル共重合体 0.06 (10)流動パラフィン 1.0 (11)ベヘニルアルコール 0.05 (12)ステアリルアルコール 0.03 (13)セルロース系水溶性高分子 1.0 (「セルロフローC25」:チッソ社製) (14)ジメチルシリコーンオイル処理無水ケイ酸 2.0 (「アエロジルR202」表面積100m2/g) (製法)(1)〜(9)を混合、溶解した後、(13)
を分散した(A相)。一方、これとは別に(10)〜
(12)を混合、溶解した(B相)。次いでB相をA相
に徐々に添加しながら乳化物を調製した。得られた乳化
物と(14)を混合、攪拌し、容器に充填した。(Example 4) (Combined component) (% by weight) (1) Xanthan gum 0.3 (2) 1,3-butylene glycol 4.0 (3) Citric acid 0.05 (4) Citric acid Sodium 0.05 (5) Preservative 0.2 (6) Potassium hydroxide 0.02 (7) Purified water residue (8) L-ascorbic acid-2-glucoside 1.0 (9) Acrylic acid / methacrylic acid Alkyl copolymer 0.06 (10) Liquid paraffin 1.0 (11) Behenyl alcohol 0.05 (12) Stearyl alcohol 0.03 (13) Cellulosic water-soluble polymer 1.0 ("Celluloflow C25": Chisso Corporation) (14) Silicic anhydride treated with dimethyl silicone oil 2.0 (“Aerosil R202” surface area 100 m 2 / g) (Production method) After mixing and dissolving (1) to (9), (13)
Was dispersed (phase A). On the other hand, apart from this (10) ~
(12) was mixed and dissolved (phase B). Next, an emulsion was prepared while gradually adding the phase B to the phase A. The obtained emulsion and (14) were mixed, stirred, and filled in a container.
【0083】実施例4の粉末化粧料は、きしみ感がな
く、きわめて良好な使用性を示し、また、薬剤安定性、
製品の長期保存安定性に優れるものであった。The powder cosmetic of Example 4 has no squeaky feeling, shows extremely good usability, and has excellent drug stability,
The product had excellent long-term storage stability.
【0084】 (実施例5) (配 合 成 分) (重量%) (1)ヒドロキシエチルセルロース 0.2 (2)トレハロース 2.0 (3)クエン酸 0.05 (4)クエン酸ナトリウム 0.05 (5)防腐剤 0.2 (6)水酸化カリウム 0.02 (7)精製水 残 余 (8)L−アスコルビン酸−2−グルコシド 1.0 (9)N−ステアロイル−L−グルタミン酸ナトリウム 0.2 (10)メチルポリシロキサン 1.0 (11)ベヘニルアルコール 0.1 (12)ステアリルアルコール 0.05 (13)無水ケイ酸 2.0 (「シルデックスL−51」;旭硝子社製) (14)ジメチルシリコーンオイル処理無水ケイ酸 20.0 (「アエロジルRY200S」、表面積80m2/g) (製法)(1)〜(9)を混合、溶解した(A相)。一
方、これとは別に(10)〜(12)を混合、溶解した
(B相)。次いでB相をA相に徐々に添加しながら乳化
物を調製した。得られた乳化物と(13)、(14)と
を混合、攪拌し、容器に充填した。(Example 5) (combination component) (% by weight) (1) hydroxyethyl cellulose 0.2 (2) trehalose 2.0 (3) citric acid 0.05 (4) sodium citrate 0.05 (5) Preservative 0.2 (6) Potassium hydroxide 0.02 (7) Purified water residue (8) L-ascorbic acid-2-glucoside 1.0 (9) N-stearoyl-L-glutamate sodium 0 .2 (10) Methylpolysiloxane 1.0 (11) Behenyl alcohol 0.1 (12) Stearyl alcohol 0.05 (13) Silicic anhydride 2.0 ("Sildex L-51"; Asahi Glass Co., Ltd.) (14) ) Silicic anhydride treated with dimethyl silicone oil 20.0 (“Aerosil RY200S”, surface area 80 m 2 / g) (Production method) (1) to (9) were mixed and dissolved (phase A). On the other hand, (10) to (12) were mixed and dissolved separately (B phase). Next, an emulsion was prepared while gradually adding the phase B to the phase A. The obtained emulsion and (13) and (14) were mixed, stirred, and filled in a container.
【0085】実施例5の粉末化粧料は、きしみ感がな
く、きわめて良好な使用性を示し、また、薬剤安定性、
製品の長期保存安定性に優れるものであった。The powder cosmetic of Example 5 has no squeaky feeling, shows extremely good usability, and has excellent drug stability and
The product had excellent long-term storage stability.
【0086】なお、上記実施例1〜5の粉末化粧料は、
いずれも良好な粉末化が得られ、また塗擦時の液化も良
好で、みずみずしい使用性を有するものであった。The powder cosmetics of Examples 1 to 5 were
In each case, good powdering was obtained, liquefaction at the time of rubbing was good, and fresh usability was obtained.
【0087】(実施例6、比較例4)下記表7に示す組
成で粉末化粧料を調製した。上記試験方法により、実施
例6、比較例4の使用性(きしみ感)、製品の長期保存
安定性を評価した。なお、表7中、カプセル分散液(A
相)(*)は、下記表6に示す組成のカプセル化油性成分
の分散液である。また、表7中、ジメチルシリコーンオ
イル処理無水ケイ酸(* )は、「アエロジルR202」
(日本アエロジル社製;表面積100m2/g)を用い
た。結果を表7に示す。(Example 6, Comparative Example 4) Powder cosmetics having the compositions shown in Table 7 below were prepared. According to the test method described above, the usability (squeaking feeling) of Example 6 and Comparative Example 4 and the long-term storage stability of the product were evaluated. In Table 7, the capsule dispersion (A
Phase) (*) is a dispersion of the encapsulated oily component having the composition shown in Table 6 below. In Table 7, silicic acid anhydride (* ) treated with dimethyl silicone oil is “Aerosil R202”.
(Manufactured by Nippon Aerosil Co., Ltd .; surface area: 100 m 2 / g). Table 7 shows the results.
【0088】[0088]
【表6】 [Table 6]
【0089】(製法)コアセルベーション法により、香
料をホホバ油に溶解したカプセル分散液(A相)を得
た。(Preparation Method) A capsule dispersion (phase A) in which a fragrance was dissolved in jojoba oil was obtained by a coacervation method.
【0090】[0090]
【表7】 [Table 7]
【0091】(製法)実施例6では、(2)〜(8)、
(10)を混合、溶解した後、A相((1))を均一分
散した(B相)。これとは別に(9)、(11)、(1
2)を混合、溶解した(C相)。次いでC相をB相に徐
々に添加しながら乳化物を調製した。得られた乳化物と
(13)を混合、攪拌し、容器に充填した。(Production method) In Example 6, (2) to (8)
After mixing and dissolving (10), phase A ((1)) was uniformly dispersed (phase B). Apart from this, (9), (11), (1
2) was mixed and dissolved (phase C). Next, an emulsion was prepared while gradually adding the phase C to the phase B. The obtained emulsion and (13) were mixed, stirred, and filled in a container.
【0092】一方、比較例4では、(2)〜(8)を混
合、溶解した後、A相((1))を均一分散した(B
相)。これと(13)を混合、攪拌し、容器に充填し
た。On the other hand, in Comparative Example 4, after mixing and dissolving (2) to (8), phase A ((1)) was uniformly dispersed (B
phase). This and (13) were mixed, stirred, and filled in a container.
【0093】表7の結果より明らかなように、実施例6
の粉末化粧料は、比較例4に比較して、きしみ感が現れ
ず、みずみずしさを有し、良好な使用性を示した。ま
た、実施例6の粉末化粧料においては、各保存条件下で
6ヵ月経過後も製剤の形態がほとんど変化せず、経時の
製剤安定性においても問題のないものであった。As is clear from the results in Table 7, Example 6
The powdery cosmetic did not show a squeaky feeling, had a freshness, and showed good usability as compared with Comparative Example 4. In the powder cosmetic of Example 6, the morphology of the preparation hardly changed even after 6 months under each storage condition, and there was no problem in the stability of the preparation over time.
【0094】[0094]
【発明の効果】本発明の粉末化粧料は、粉末でありなが
ら、使用時塗擦によって液化し、使用中に清涼感、しっ
とり感を与え、しかも肌への親和性に優れ、エモリエン
ト性、水分等を付与することができるとともに、きしみ
感の全くないきわめて良好な使用感および仕上がりを得
ることができる。また、製品の長期保存安定性にも優れ
る。さらに、従来化粧品への配合が難しいとされていた
水存在下不安定成分を組成中に長期間に亘り安定に保持
することができるので、新しいタイプの化粧料として広
く利用が可能である。The powder cosmetic of the present invention, while being a powder, is liquefied by rubbing at the time of use, gives a refreshing feeling and moist feeling during use, and is excellent in affinity for skin, emollient, moisture, etc. And a very good feeling of use and finish without any squeaky feeling can be obtained. In addition, the product has excellent long-term storage stability. Furthermore, since the unstable component in the presence of water, which has conventionally been considered difficult to be incorporated into cosmetics, can be stably maintained in the composition for a long period of time, it can be widely used as a new type of cosmetic.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 古賀 信義 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第一リサーチセンター内 (72)発明者 高須 恵美子 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第一リサーチセンター内 (72)発明者 西山 聖二 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第一リサーチセンター内 (72)発明者 梁木 利男 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第一リサーチセンター内 ──────────────────────────────────────────────────の Continued on the front page (72) Inventor Nobuyoshi Koga 1050 Nippa-cho, Kohoku-ku, Yokohama, Kanagawa Prefecture Inside Shiseido Daiichi Research Center Co., Ltd. (72) Emiko Takasu 1050 Nippa-cho, Kohoku-ku, Yokohama, Kanagawa Inside Shiseido Daiichi Research Center Co., Ltd. (72) Inventor Seiji Nishiyama 1050 Nippa-cho, Kohoku-ku, Yokohama, Kanagawa Prefecture Inside 72 Shiseido Daiichi Research Center Co., Ltd. 1050 Inside Shiseido Daiichi Research Center Co., Ltd.
Claims (6)
無水ケイ酸と、(b)水中油型乳化組成物を1種または
2種以上とを含有する、塗擦により液化する粉末化粧
料。1. A powder cosmetic composition comprising (a) a hydrophobic silicic anhydride having a surface area of 60 m 2 / g or more and (b) one or more oil-in-water emulsion compositions, which is liquefied by rubbing. .
請求項1記載の粉末化粧料。2. The composition according to claim 1, wherein the component (a) contains 2 to 20% by weight.
The powder cosmetic according to claim 1.
する、請求項1または2記載の粉末化粧料。3. The powder cosmetic according to claim 1, further comprising (c) an unstable component in the presence of water.
剤、ホルモン剤、ビタミン類、酵素、抗酸化剤、植物抽
出液の中から選ばれる1種または2種以上である、請求
項3記載の粉末化粧料。4. The component (c) is one or more selected from whitening agents, anti-inflammatory agents, antibacterial agents, hormonal agents, vitamins, enzymes, antioxidants, and plant extracts. The powder cosmetic according to claim 3.
コウジ酸、L−アスコルビン酸およびその誘導体、パン
トテニールエチルエーテル、トラネキサム酸およびその
誘導体、グリチルリチン酸塩、レゾルシン、イオウ、サ
リチル酸、ビタミンB6およびその誘導体、ニコチン酸
およびその誘導体、トリプシン、ヒアルロニダーゼ、チ
オタウリン、グルタチオン、茶エキス、イザヨイバラエ
キスの中から選ばれる1種または2種以上である、請求
項3または4記載の粉末化粧料(5) The component (c) is a hydroquinone derivative,
Kojic acid, L- ascorbic acid and its derivatives, pantothenyl ethyl ether, tranexamic acid and its derivatives, glycyrrhizin salts, resorcinol, sulfur, salicylic acid, vitamin of B 6 and derivatives thereof, nicotinic acid and its derivatives, trypsin, hyaluronidase, thiotaurine The powder cosmetic according to claim 3, wherein the cosmetic is at least one selected from the group consisting of, glutathione, tea extract, and Izayobara extract.
有する、請求項3〜5のいずれか1項に記載の粉末化粧
料。6. The powder cosmetic according to claim 3, which contains 0.001 to 10% by weight of the component (c).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000044146A JP2000309505A (en) | 1999-02-26 | 2000-02-22 | Powder cosmetic |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11-51930 | 1999-02-26 | ||
JP5193099 | 1999-02-26 | ||
JP2000044146A JP2000309505A (en) | 1999-02-26 | 2000-02-22 | Powder cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000309505A true JP2000309505A (en) | 2000-11-07 |
Family
ID=26392516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000044146A Pending JP2000309505A (en) | 1999-02-26 | 2000-02-22 | Powder cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2000309505A (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002056844A1 (en) * | 2001-01-18 | 2002-07-25 | Shiseido Company, Ltd. | Process for producing dry water |
JP2002326904A (en) * | 2001-05-08 | 2002-11-15 | Shiseido Co Ltd | Powdery cosmetic |
WO2003003990A1 (en) * | 2001-07-05 | 2003-01-16 | Shiseido Company, Ltd. | Powdery composition |
JP2003081733A (en) * | 2001-07-05 | 2003-03-19 | Shiseido Co Ltd | Powdery composition |
JP2003514840A (en) * | 1999-11-23 | 2003-04-22 | カラー アクセス,インコーポレイティド | Powder-liquid composition |
EP1457191A3 (en) * | 2003-03-13 | 2004-09-29 | Coty B.V. | Cosmetic powder based on silicium dioxide and process for preparing it |
JP2004323361A (en) * | 2003-04-21 | 2004-11-18 | New Hair Keshoryo Honpo:Kk | Bleaching powder |
JP2005511715A (en) * | 2001-11-09 | 2005-04-28 | オア−レ−オア リミテッド | Agate cream containing hydrophilic and hydrophobic particles |
JP2005154325A (en) * | 2003-11-25 | 2005-06-16 | New Hair Keshoryo Honpo:Kk | Hydrous powder cosmetic base and cosmetic |
JP2006335670A (en) * | 2005-06-01 | 2006-12-14 | Shiseido Co Ltd | Powdery cosmetic |
JP2008521760A (en) * | 2004-11-25 | 2008-06-26 | エボニック デグサ ゲーエムベーハー | Powdered cosmetic formulations with high water content |
WO2011076518A1 (en) | 2009-12-26 | 2011-06-30 | Evonik Degussa Gmbh | Water containing powder composition |
US8192748B2 (en) * | 2002-03-11 | 2012-06-05 | Kao Corporation | Cosmetic composition exhibiting water-runability, its manufacture and use |
JP2014047162A (en) * | 2012-08-31 | 2014-03-17 | Nippon Menaade Keshohin Kk | Hydrous powder cosmetic |
US9468606B2 (en) | 2014-03-31 | 2016-10-18 | Johnson & Johnson Consumer Inc. | Compostions and methods for enhancing the topical application of an acidic benefit agent |
US9474699B2 (en) | 2014-03-31 | 2016-10-25 | Johnson & Johnson Consumer Inc. | Compostions and methods for enhancing the topical application of a basic benefit agent |
JP2017081906A (en) * | 2015-10-23 | 2017-05-18 | シー アンド シー インターナショナル カンパニー,リミテッド | Lasting powder essence compositions in which coloring and feeling of use are improved, and production methods thereof |
JP2017178938A (en) * | 2016-03-25 | 2017-10-05 | 株式会社コーセー | Hydrous powder cosmetic |
US9795545B2 (en) | 2014-06-16 | 2017-10-24 | Johnson & Johnson Consumer Inc. | Compositions and methods for enhancing the topical application of a color cosmetic |
KR20180061783A (en) | 2016-11-30 | 2018-06-08 | (주)바이오제닉스 | Process for producing dry water |
JP2018168134A (en) * | 2017-03-30 | 2018-11-01 | 株式会社コーセー | Oil-in-water type cosmetic |
CN110799170A (en) * | 2017-06-26 | 2020-02-14 | 欧莱雅 | Powdery cosmetic composition based on an oil-in-water dispersion coated with hydrophobic silica aerogel particles |
-
2000
- 2000-02-22 JP JP2000044146A patent/JP2000309505A/en active Pending
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003514840A (en) * | 1999-11-23 | 2003-04-22 | カラー アクセス,インコーポレイティド | Powder-liquid composition |
JPWO2002056844A1 (en) * | 2001-01-18 | 2004-05-20 | 株式会社資生堂 | Dry water production method |
WO2002056844A1 (en) * | 2001-01-18 | 2002-07-25 | Shiseido Company, Ltd. | Process for producing dry water |
CN100398085C (en) * | 2001-01-18 | 2008-07-02 | 株式会社资生堂 | Process for producing dry water |
JP2002326904A (en) * | 2001-05-08 | 2002-11-15 | Shiseido Co Ltd | Powdery cosmetic |
WO2003003990A1 (en) * | 2001-07-05 | 2003-01-16 | Shiseido Company, Ltd. | Powdery composition |
JP2003081733A (en) * | 2001-07-05 | 2003-03-19 | Shiseido Co Ltd | Powdery composition |
JP2005511715A (en) * | 2001-11-09 | 2005-04-28 | オア−レ−オア リミテッド | Agate cream containing hydrophilic and hydrophobic particles |
US8192748B2 (en) * | 2002-03-11 | 2012-06-05 | Kao Corporation | Cosmetic composition exhibiting water-runability, its manufacture and use |
EP1457191A3 (en) * | 2003-03-13 | 2004-09-29 | Coty B.V. | Cosmetic powder based on silicium dioxide and process for preparing it |
JP2004323361A (en) * | 2003-04-21 | 2004-11-18 | New Hair Keshoryo Honpo:Kk | Bleaching powder |
JP2005154325A (en) * | 2003-11-25 | 2005-06-16 | New Hair Keshoryo Honpo:Kk | Hydrous powder cosmetic base and cosmetic |
JP4700903B2 (en) * | 2003-11-25 | 2011-06-15 | 株式会社ニューヘヤー化粧料本舗 | Hydrous powder cosmetic base and cosmetic |
JP2008521760A (en) * | 2004-11-25 | 2008-06-26 | エボニック デグサ ゲーエムベーハー | Powdered cosmetic formulations with high water content |
EP1814513B1 (en) * | 2004-11-25 | 2009-07-15 | Evonik Degussa GmbH | Pulverulent cosmetic formulation having a high water content |
JP4566067B2 (en) * | 2005-06-01 | 2010-10-20 | 株式会社資生堂 | Powder cosmetics |
JP2006335670A (en) * | 2005-06-01 | 2006-12-14 | Shiseido Co Ltd | Powdery cosmetic |
WO2011076518A1 (en) | 2009-12-26 | 2011-06-30 | Evonik Degussa Gmbh | Water containing powder composition |
JP2014047162A (en) * | 2012-08-31 | 2014-03-17 | Nippon Menaade Keshohin Kk | Hydrous powder cosmetic |
US9468606B2 (en) | 2014-03-31 | 2016-10-18 | Johnson & Johnson Consumer Inc. | Compostions and methods for enhancing the topical application of an acidic benefit agent |
US9474699B2 (en) | 2014-03-31 | 2016-10-25 | Johnson & Johnson Consumer Inc. | Compostions and methods for enhancing the topical application of a basic benefit agent |
US9795545B2 (en) | 2014-06-16 | 2017-10-24 | Johnson & Johnson Consumer Inc. | Compositions and methods for enhancing the topical application of a color cosmetic |
JP2017081906A (en) * | 2015-10-23 | 2017-05-18 | シー アンド シー インターナショナル カンパニー,リミテッド | Lasting powder essence compositions in which coloring and feeling of use are improved, and production methods thereof |
JP2017178938A (en) * | 2016-03-25 | 2017-10-05 | 株式会社コーセー | Hydrous powder cosmetic |
KR20180061783A (en) | 2016-11-30 | 2018-06-08 | (주)바이오제닉스 | Process for producing dry water |
JP2018168134A (en) * | 2017-03-30 | 2018-11-01 | 株式会社コーセー | Oil-in-water type cosmetic |
CN110799170A (en) * | 2017-06-26 | 2020-02-14 | 欧莱雅 | Powdery cosmetic composition based on an oil-in-water dispersion coated with hydrophobic silica aerogel particles |
CN110799170B (en) * | 2017-06-26 | 2022-12-30 | 欧莱雅 | Powdery cosmetic composition based on an oil-in-water dispersion coated with hydrophobic silica aerogel particles |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000309505A (en) | Powder cosmetic | |
JP6535329B2 (en) | Oil-in-water emulsion composition | |
JP4029978B2 (en) | Method for producing dry water | |
JP4514902B2 (en) | Water-containing powder composition, process for producing the same, and cosmetics containing the powder composition | |
JP3535389B2 (en) | External composition | |
JP3666844B2 (en) | Powder cosmetics | |
WO2003061608A1 (en) | Water-in-oil emulsion composition and emulsion cosmetic comprising the same | |
JP2018008910A (en) | Sunscreen cosmetics | |
JP2022176753A (en) | Zinc oxide particle dispersion and cosmetics containing the same | |
JP2000309506A (en) | Powder cosmetic | |
JP2002326904A (en) | Powdery cosmetic | |
JP7404651B2 (en) | Oil-in-water emulsion cosmetic and method for producing the same | |
JPH09255543A (en) | W/o-type anti-suntan cosmetic | |
JPH07267819A (en) | Water in oil type emulsion cosmetic | |
JP3511415B2 (en) | Composite powder and cosmetics | |
JP2001220316A (en) | Cosmetic composition | |
JPH09255544A (en) | W/o-type anti-suntan cosmetic | |
JP5088766B2 (en) | Oil fine dispersion composition | |
JP2000204276A (en) | Water-in-oil emulsion composition | |
JP2017178938A (en) | Hydrous powder cosmetic | |
JP4700903B2 (en) | Hydrous powder cosmetic base and cosmetic | |
JPH08259432A (en) | Water-in-oil type emulsion preparation | |
JP7604221B2 (en) | Oil-in-water emulsion cosmetics | |
JPH11209234A (en) | Cool cosmetic | |
JP4160490B2 (en) | Water-in-oil emulsion composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040701 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050210 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050411 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050502 |